The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Near-Patient Molecular Solutions Market Expected To Change From 2026 To 2030?
The near-patient molecular solutions market has demonstrated significant expansion in recent years. Its size is forecast to rise from $4.54 billion in 2025 to $4.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The driving forces behind this past growth include the broader adoption of molecular diagnostic techniques, the requirement for quick test processing times, the distribution of laboratory services, the expansion of diagnostic settings outside of hospitals, and the use of portable diagnostic devices.
The near-patient molecular solutions market size is expected to undergo significant expansion in the coming years, with projections indicating it will reach $7.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is primarily attributed to a heightened focus on personalized medicine, increasing demand for home and remote testing solutions, advancements in miniaturized molecular platforms, the expansion of infectious disease surveillance, and greater integration with digital health ecosystems. Major trends foreseen for the same period include a growing adoption of point-of-care molecular testing devices, an escalating demand for rapid infectious disease diagnostics, the increasing incorporation of portable PCR platforms, the development of decentralized diagnostic infrastructure, and an enhanced emphasis on the accuracy of near-patient testing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp
What Significant Factors Are Influencing The Near-Patient Molecular Solutions Market Expansion?
The expansion of the near patient molecular solutions market is anticipated to be fueled by the increasing need for home-based point-of-care devices. These devices are diagnostic systems used by individuals or non-lab personnel at or close to their residences, facilitating sample gathering, analysis, or result interpretation away from a traditional central laboratory and near the point of care. The increasing demand for home-based point-of-care devices stems from consumers’ growing preference for health monitoring that is convenient, fast, and easily accessible beyond conventional healthcare environments. Near-patient molecular solutions aid these home-based devices by offering precise, swift, and portable molecular diagnostics suitable for dependable use outside standard laboratory environments. An illustration of this trend is the report from the US Food & Drug Administration (FDA), a US-based government agency, in its 2023 COVID-19 testing update in February 2023. This report indicated the presence of one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Consequently, the increasing need for home-based point-of-care devices is a significant factor boosting the expansion of the near patient molecular solutions market.
How Is The Near-Patient Molecular Solutions Market Segmented Across Different Segment Categories?
The near-patient molecular solutions market covered in this report is segmented –
1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based
3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users
Subsegments:
1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits
2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits
3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits
4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits
5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits
6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips
7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits
8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits
9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits
10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits
What Trends Are Affecting The Direction Of The Near-Patient Molecular Solutions Market?
Leading companies operating within the near-patient molecular solutions market are focusing on integrating technological advancements, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic accuracy. Isothermal nucleic acid amplification is an advanced molecular diagnostic technology that amplifies target nucleic acid sequences at a consistent temperature, removing the necessity for thermal cycling present in conventional polymerase chain reaction (PCR), thereby enabling fast, sensitive, and compact molecular testing. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, received FDA marketing authorization for its Cue COVID-19 Molecular Test. This isothermal amplification-based diagnostic device is designed for the at-home and point-of-care detection of SARS-CoV-2 RNA. The system includes a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that guides users through the testing process and provides molecular results in about 20 minutes. The Cue COVID-19 molecular test enhances access to accurate molecular-level diagnostics, shortens turnaround time, and supports real-time health decision-making outside of traditional laboratory environments.
Which Organizations Play A Role In The Near-Patient Molecular Solutions Market Landscape?
Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.
Get The Full Near-Patient Molecular Solutions Market Report:
Which Region Is The Leading Market For The Near-Patient Molecular Solutions Market?
North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Near-Patient Molecular Solutions Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company
Household Insecticides Market Report 2026
https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report
Edible Insects Market Report
https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report
Tick Repellent Market Report
https://www.thebusinessresearchcompany.com/report/tick-repellent-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model